202 related articles for article (PubMed ID: 21274875)
61. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.
Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS
Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158
[TBL] [Abstract][Full Text] [Related]
62. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats.
Chen WY; Lin SY; Pan HC; Liao SL; Chuang YH; Yen YJ; Lin SY; Chen CJ
J Nutr Biochem; 2012 Mar; 23(3):252-64. PubMed ID: 21497498
[TBL] [Abstract][Full Text] [Related]
63. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats.
Moczydlowska J; Miltyk W; Hermanowicz A; Lebensztejn DM; Palka JA; Debek W
J Invest Surg; 2017 Feb; 30(1):41-46. PubMed ID: 27260943
[TBL] [Abstract][Full Text] [Related]
64. Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis.
Yang YY; Huang YT; Lee KC; Lee FY; Lee TY; Hou MC; Lin HC; Lee SD
Clin Sci (Lond); 2009 Jan; 116(1):71-9. PubMed ID: 18479249
[TBL] [Abstract][Full Text] [Related]
65. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
[TBL] [Abstract][Full Text] [Related]
66. Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets.
Paumgartner G
World J Gastroenterol; 2006 Jul; 12(28):4445-51. PubMed ID: 16874853
[TBL] [Abstract][Full Text] [Related]
67. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit
Hargrove L; Kennedy L; Demieville J; Jones H; Meng F; DeMorrow S; Karstens W; Madeka T; Greene J; Francis H
Hepatology; 2017 Jun; 65(6):1991-2004. PubMed ID: 28120369
[TBL] [Abstract][Full Text] [Related]
68. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC
Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076
[TBL] [Abstract][Full Text] [Related]
69. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
Song M; Song Z; Barve S; Zhang J; Chen T; Liu M; Arteel GE; Brewer GJ; McClain CJ
J Pharmacol Exp Ther; 2008 May; 325(2):409-16. PubMed ID: 18299419
[TBL] [Abstract][Full Text] [Related]
70. The effects of hyperbaric oxygen application against cholestatic oxidative stress and hepatic damage after bile duct ligation in rats.
Ayvaz S; Kanter M; Aksu B; Sahin SH; Uzun H; Erboga M; Pul M
J Surg Res; 2013 Jul; 183(1):146-55. PubMed ID: 23462455
[TBL] [Abstract][Full Text] [Related]
71. Aqueous extract of Artemisia iwayomogi Kitamura attenuates cholestatic liver fibrosis in a rat model of bile duct ligation.
Han JM; Kim HG; Choi MK; Lee JS; Park HJ; Wang JH; Lee JS; Son SW; Hwang SY; Son CG
Food Chem Toxicol; 2012 Oct; 50(10):3505-13. PubMed ID: 22824087
[TBL] [Abstract][Full Text] [Related]
72. Effectiveness of the PPARγ agonist, GW570, in liver fibrosis.
Yang L; Stimpson SA; Chen L; Wallace Harrington W; Rockey DC
Inflamm Res; 2010 Dec; 59(12):1061-71. PubMed ID: 20585829
[TBL] [Abstract][Full Text] [Related]
73. CGX, a multiple herbal drug, improves cholestatic liver fibrosis in a bile duct ligation-induced rat model.
Kim HG; Han JM; Lee HW; Lee JS; Son SW; Choi MK; Lee DS; Wang JH; Son CG
J Ethnopharmacol; 2013 Jan; 145(2):653-62. PubMed ID: 23228913
[TBL] [Abstract][Full Text] [Related]
74. Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats.
Qian H; Shi J; Fan TT; Lv J; Chen SW; Song CY; Zheng ZW; Xie WF; Chen YX
World J Gastroenterol; 2014 Feb; 20(7):1822-32. PubMed ID: 24587659
[TBL] [Abstract][Full Text] [Related]
75. Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
Marzioni M; Francis H; Benedetti A; Ueno Y; Fava G; Venter J; Reichenbach R; Mancino MG; Summers R; Alpini G; Glaser S
Am J Pathol; 2006 Feb; 168(2):398-409. PubMed ID: 16436655
[TBL] [Abstract][Full Text] [Related]
76. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Weiglein AH; Lammert F; Marschall HU; Tsybrovskyy O; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2002 Oct; 123(4):1238-51. PubMed ID: 12360485
[TBL] [Abstract][Full Text] [Related]
77. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.
Woolbright BL; Antoine DJ; Jenkins RE; Bajt ML; Park BK; Jaeschke H
Toxicol Appl Pharmacol; 2013 Dec; 273(3):524-31. PubMed ID: 24096036
[TBL] [Abstract][Full Text] [Related]
78. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
[TBL] [Abstract][Full Text] [Related]
79. Effects of andrographolide on intrahepatic cholestasis induced by alpha-naphthylisothiocyanate in rats.
Khamphaya T; Chansela P; Piyachaturawat P; Suksamrarn A; Nathanson MH; Weerachayaphorn J
Eur J Pharmacol; 2016 Oct; 789():254-264. PubMed ID: 27475677
[TBL] [Abstract][Full Text] [Related]
80. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
